| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.39B | 10.75B | 10.18B | 9.20B | 7.17B |
| Gross Profit | 4.19B | 3.88B | 3.56B | 3.15B | 2.60B |
| EBITDA | 1.70B | 1.62B | 1.38B | 1.22B | 1.13B |
| Net Income | 923.42M | 820.60M | 636.50M | 415.40M | 547.20M |
Balance Sheet | |||||
| Total Assets | 11.61B | 10.65B | 9.88B | 9.86B | 8.51B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.45B | 1.93B | 1.75B | 1.62B |
| Total Debt | 4.13B | 3.98B | 3.42B | 3.42B | 2.94B |
| Total Liabilities | 7.67B | 7.35B | 6.69B | 6.47B | 5.40B |
| Stockholders Equity | 3.85B | 3.21B | 3.09B | 3.28B | 3.11B |
Cash Flow | |||||
| Free Cash Flow | 732.53M | 776.50M | 776.00M | 711.20M | 635.70M |
| Operating Cash Flow | 1.47B | 1.39B | 1.39B | 1.23B | 1.14B |
| Investing Cash Flow | -4.42M | -820.90M | -268.80M | -1.08B | -1.26B |
| Financing Cash Flow | -555.09M | -205.50M | -412.40M | -198.70M | -322.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £15.42B | 17.33 | 28.56% | 1.96% | 6.00% | 42.42% | |
72 Outperform | £332.71M | 16.26 | 23.59% | 3.39% | 3.04% | -6.67% | |
70 Outperform | £688.62M | 7.17 | 15.23% | 2.74% | 3.97% | 34.09% | |
66 Neutral | £31.18B | 5.98 | 19.40% | 5.00% | -2.83% | -40.42% | |
65 Neutral | £405.90M | 9.36 | 3.72% | 4.05% | -2.22% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | £896.49M | 16.71 | 9.32% | 2.11% | -6.03% | 13.11% |